Epigenomics Completes Submission of CRC Test to FDA
January 07, 2013
Epigenomics Completes Submission of CRC Test to FDA
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology
May 22, 2013 / Pharmacogenomics Reporter - Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter - Epigenomics' Q1 Revenues Increase 46 Percent
May 8, 2013 / GenomeWeb Daily News - With Top-line Deep-C Trial Data, Exact Sciences Gears Up for FDA and CMS Submissions for Cologuard
April 24, 2013 / Pharmacogenomics Reporter - Insight's PCR-Based ALK Test Development Moves Forward with NCI's Help
April 10, 2013 / Pharmacogenomics Reporter